Loading clinical trials...
Loading clinical trials...
The Effects of Reduced Dose Alemtuzumab for Severe Kidney Transplant Rejection
Conditions
Locations
1
Netherlands
Erasmus MC
Rotterdam, South Holland, Netherlands
Start Date
December 1, 2023
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2026
Last Updated
February 21, 2024
NCT07412470
NCT07006532
NCT04736381
NCT04702022
NCT06825117
NCT04953715
Lead Sponsor
Erasmus Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions